Young Cancer Survivors Face Higher Risk of Death From Second Malignancies Study finds 25% higher risk of secondary cancers versus general public, 84% higher risk of death May 04, 2022
Corticosteroids Linked to Pain Events in Patients With Sickle Cell Disease Hospitalization risk for vaso-occlusive episodes four times higher after exposure May 02, 2022
Durvalumab Combinations Push the Response Envelope in Unresectable NSCLC Big increases in response, disease control with the addition of anti-CD73, anti-NKG2A agents May 02, 2022
Longer Ischemia Time Not Tied to Higher Complication Rate in Free-Tissue Transfer Main focus of microvascular surgery should be best possible H&N reconstruction, researchers say May 01, 2022
Menstrual Cycles Point to Link Between Sex Hormones and Long QT Research suggests new tools for risk stratification and therapy May 01, 2022
Ambient Dirty Air May Put Some People at Higher Risk for Head and Neck Cancers Diesel particulate levels tied to increased oral and pharyngeal cancer incidence in one state May 01, 2022
Immunotherapy Before Head and Neck Surgery Doesnβt Add to Complications Definitive surgery can be conducted safely after neoadjuvant immunotherapy, researchers conclude May 01, 2022
End of the Line for a Failed Prostate Cancer Drug Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
Another Robotic Approach for Bladder Cancer Removal Proves Its Mettle Robot-assisted laparoscopy with ICUD tied to better survival versus open surgery Apr 29, 2022
Program to Reduce Opioid Scripts Post-Surgery Worked for Thyroid Cancer Patients Post-surgical intervention may help to reduce the risk of opioid addiction and overdose Apr 29, 2022
New Guidelines Target Cancer Risk in Rare GI Syndromes Task force focuses on diagnosis, management of gastrointestinal hamartomatous polyposis syndromes Apr 28, 2022
When Free Flaps Fail Twice, Another Try Can Be Successful Second salvage attempt worked in 30% of cases Apr 28, 2022
Topical Antisepsis May Thwart SSIs in Upper Aerodigestive Tract Reconstruction Preoperative topical antisepsis mucosal preparation associated with 51% fewer infections Apr 28, 2022
Allo-Transplant With Omidubicel Hints at Longer-Term Benefits Too "Viable" option for patients eligible for umbilical cord blood transplantation, investigator says Apr 27, 2022
Promising Data for Allo-Transplant After CAR T-Cell Failure in LBCL Durable responses with no unexpected or prolonged safety issues Apr 27, 2022
Another Link Between Prostate Cancer Hormone Tx and Impaired Cognition Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
Eprenetapopt-Based Combo Impresses in TP53-Mutant AML/MDS 1-year relapse-free survival rate of 60% with maintenance therapy after transplant Apr 25, 2022
Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparency News, features, and commentary about cancer-related issues Apr 22, 2022
What Does It Take to Confirm a Cancer Cluster? Suspicions are raised at a New Jersey high school, but the road ahead is likely a long one Apr 22, 2022
Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx Consistently low PSA levels failed to signal metastasis Apr 18, 2022
Intratumoral Combo Shrinks Melanomas Refractory to Anti-PD-1 But response rate driven primarily by injected lesions, expert points out Apr 14, 2022
Anti-CD39 Combination Therapy Promising in Gastric/GEJ Cancer Responses in a majority of patients, evidence of durability with TTX-030, chemoimmunotherapy Apr 14, 2022
BTK Inhibitor Shows Potential in Immune Thrombocytopenia Across doses, 40% of heavily pretreated patients responded to oral rilzabrutinib Apr 13, 2022
Dual Immunotherapy Improves PFS in Melanoma Resistant to Anti-PD-1 Six-month PFS rate more than doubled with nivolumab/ipilimumab versus ipilimumab alone Apr 13, 2022
Boosting Responses to Neoadjuvant Therapy in Resectable NSCLC Multi-drug platform study identifies promising durvalumab-based combinations Apr 12, 2022
Neoadjuvant Nivolumab a 'New Standard' in Lung Cancer "Another quantum leap in lung cancer therapy," expert says Apr 12, 2022
Genetic Score Shows Promise for Honing PSA Precision Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
PARP Inhibitor-Based Triplet Promising in Endometrial Cancer Olaparib/cyclophosphamide/metformin combo appears effective in older, heavily pretreated patients Apr 11, 2022
Longer-Term Sotorasib Data 'Encouraging' in KRAS-Mutated NSCLC Prolonged tumor response seen in 2-year analysis Apr 11, 2022
DCIS Recurrence Often Represents a New Primary Breast Cancer Almost a fifth of cases unrelated to primary DCIS, raising questions about current treatment Apr 11, 2022
Bispecific Antibody-NK Cell Complex Impresses in Early Hodgkin/NHL Trial Objective responses in 89% of patients with no CRS, neurotoxicity, or graft-versus-host disease Apr 11, 2022
RT Prior to Mastectomy, Reconstruction Shows Promise U.K. study demonstrates low complication rates and good aesthetic results Apr 08, 2022
Is Sentinel Node Biopsy Necessary for Older Breast Cancer Patients? Study finds positive lymph nodes not an indicator for chemotherapy Apr 07, 2022
$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rights Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
New Clue to Risk of Peritoneal Cancer After Prophylactic Salpingo-Oophorectomy Women with BRCA variant and serous tubal intraepithelial carcinoma had a 34-fold greater risk Apr 05, 2022
Black Patients More Often Get 'Substandard' Care for GI Cancers Retrospective study finds worse surgical outcomes, lower odds of receiving chemotherapy Apr 04, 2022
Living Donor Transplant Promising for CRC With Liver-Only Metastases In small study, researchers see "encouraging" survival outcomes Mar 30, 2022
Pumping (IV) Iron Linked to Varying Anaphylaxis Risk for Older Adults Study finds risk was low, but unequal across different products Mar 28, 2022
3D Mammograms Deliver Fewer False-Positive Findings However, half of women will have a false positive with annual screening with DBT Mar 25, 2022
Triplet Induction Regimen Bests Doublet for Nasopharyngeal Carcinoma Three drugs reduced risk of disease failure, but longer follow-up needed to assess OS Mar 25, 2022
